A biphenyl inhibitor of eIF4E targeting an internal binding site enables the design of cell-permeable PROTAC-degraders-Reference-Cited by-同舟云学术

A biphenyl inhibitor of eIF4E targeting an internal binding site enables the design of cell-permeable PROTAC-degraders

Published:2021-07 Issue: Volume:219 Page:113435
ISSN:0223-5234
Container-title:European Journal of Medicinal Chemistry
language:en
Short-container-title:European Journal of Medicinal Chemistry

Author:

Fischer Patrick D.^ORCID,Papadopoulos Evangelos^ORCID,Dempersmier Jon M.^ORCID,Wang Zi-Fu,Nowak Radosław P.,Donovan Katherine A.^ORCID,Kalabathula Joann,Gorgulla Christoph^ORCID,Junghanns Pierre P.M.,Kabha Eihab,Dimitrakakis Nikolaos,Petrov Ognyan I.,Mitsiades Constantine,Ducho Christian^ORCID,Gelev Vladimir,Fischer Eric S.,Wagner Gerhard^ORCID,Arthanari Haribabu^ORCID

Funder

NCI

NIGMS

Publisher

Elsevier BV

Subject

Organic Chemistry,Drug Discovery,Pharmacology,General Medicine

Reference59 articles.

1. Cap-dependent translation initiation factor eIF4E: an emerging anticancer drug target: cap-dependent translation initiation EIF4E inhibition;Jia;Med. Res. Rev.,2012

2. eIF4E – from translation to transformation;Mamane;Oncogene,2004

3. Regulation of translation initiation in eukaryotes: mechanisms and biological targets;Sonenberg;Cell,2009

4. eIF4E is a central node of an RNA regulon that governs cellular proliferation;Culjkovic;JCB (J. Cell Biol.),2006

5. Single-well monitoring of Protein−Protein interaction and Phosphorylation−Dephosphorylation events;Arcand;Biochemistry,2010

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Nano-Proteolysis Targeting Chimeras (Nano-PROTACs) in Cancer Therapy;International Journal of Nanomedicine;2024-06

2. Structural and Dynamical Analyses of Apo and Cap-binding eIF4E: Anin silicoStudy;2024-05-19

3. miR-483-5p orchestrates the initiation of protein synthesis by facilitating the decrease in phosphorylated Ser209eIF4E and 4E-BP1 levels;Scientific Reports;2024-02-20

4. Quinoline‐based thiazolyl‐hydrazones target cancer cells through autophagy inhibition;Archiv der Pharmazie;2023-11-22

5. Unlocking the potential of PROTACs: A comprehensive review of protein degradation strategies in disease therapy;Bioorganic Chemistry;2023-10